LUDELVA Trademark

Trademark Overview

On Thursday, October 3, 2019, a trademark application was filed for LUDELVA with the United States Patent and Trademark Office. The USPTO has given the LUDELVA trademark a serial number of 88640338. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 15, 2023. This trademark is owned by AbbVie AB. The LUDELVA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
ludelva

General Information

Serial Number88640338
Word MarkLUDELVA
Filing DateThursday, October 3, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 15, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2020

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 7, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie AB
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSolna 17154
SE
Party NameAbbVie AB
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSolna 17154
SE

Trademark Events

Event DateEvent Description
Monday, May 15, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 15, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 25, 2022SOU EXTENSION 5 GRANTED
Friday, October 14, 2022SOU EXTENSION 5 FILED
Tuesday, October 25, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 14, 2022TEAS EXTENSION RECEIVED
Thursday, March 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 15, 2022SOU EXTENSION 4 GRANTED
Tuesday, March 15, 2022SOU EXTENSION 4 FILED
Tuesday, March 15, 2022TEAS EXTENSION RECEIVED
Saturday, October 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 7, 2021SOU EXTENSION 3 GRANTED
Thursday, October 7, 2021SOU EXTENSION 3 FILED
Thursday, October 7, 2021TEAS EXTENSION RECEIVED
Monday, August 30, 2021ASSIGNED TO EXAMINER
Wednesday, April 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 12, 2021SOU EXTENSION 2 GRANTED
Monday, April 12, 2021SOU EXTENSION 2 FILED
Monday, April 12, 2021TEAS EXTENSION RECEIVED
Wednesday, October 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 5, 2020SOU EXTENSION 1 GRANTED
Monday, October 5, 2020SOU EXTENSION 1 FILED
Monday, October 5, 2020TEAS EXTENSION RECEIVED
Tuesday, April 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 16, 2020ASSIGNED TO LIE
Monday, January 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 8, 2020ASSIGNED TO EXAMINER
Monday, October 7, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 7, 2019NEW APPLICATION ENTERED

Related Keywords

ludelva gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related